Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-041552)

Filing Details

Accession Number:: 0001209191-13-041552
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-20 16:29:56
Reporting Period:: 2013-08-19

Filing Date:: 2013-08-20
Accepted Time:: 2013-08-20 16:29:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
861838	Idera Pharmaceuticals Inc.	IDRA	Biological Products, (No Disgnostic Substances) (2836)	043072298

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1239746	A James Geraghty	C/O Idera Pharmaceuticals, Inc. 167 Sidney St. Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-08-19	300,000	$1.75	300,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase price reported represents the weighted average purchase price of shares purchased in multiple transactions at prices ranging from $1.70 to $2.00 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.